Related Experiment Video
Updated: Jan 21, 2026

Modeling Spontaneous Metastatic Renal Cell Carcinoma mRCC in Mice Following Nephrectomy
Published on: April 29, 2014
Inhibition of UCH-L1 Deubiquitinating Activity with Two Forms of LDN-57444 Has Anti-Invasive Effects in Metastatic
Eiji Kobayashi1,2, Duhyeong Hwang3, Anjali Bheda-Malge1
1Lineberger Comprehensive Cancer Center, UNC at Chapel Hill, Department of Immunology and Microbiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Abstract:
Normally ubiquitin C-terminal hydrolase L1 (UCH-L1) is expressed in the central nervous and reproductive systems of adults, but its de novo expression has been detected in many human cancers. There is a growing body of evidence that UCH-L1 de-ubiquitinating (DUB) activity plays a major pro-metastatic role in certain carcinomas. Here we tested anti-metastatic effects of the small-molecule inhibitor of UCH-L1 DUB activity, LDN-57444, in cell lines from advanced oral squamous cell carcinoma (OSCC) as well as invasive nasopharyngeal (NP) cell lines expressing the major pro-metastatic gene product of Epstein-Barr virus (EBV) tumor virus, LMP1. To overcome the limited aqueous solubility of LDN-57444 we developed a nanoparticle formulation of LDN-57444 by incorporation of the compound in polyoxazoline micellear nanoparticles (LDN-POx). LDN-POx nanoparticles were equal in effects as the native compound in vitro. Our results demonstrate that inhibition of UCH-L1 DUB activity with LDN or LDN-POx inhibits secretion of exosomes and reduces levels of the pro-metastatic factor in exosomal fractions. Both forms of UCH-L1 DUB inhibitor suppress motility of metastatic squamous carcinoma cells as well as nasopharyngeal cells expressing EBV pro-metastatic Latent membrane protein 1 (LMP1) in physiological assays. Moreover, treatment with LDN and LDN-POx resulted in reduced levels of pro-metastatic markers, a decrease of carcinoma cell adhesion, as well as inhibition of extra-cellular vesicle (ECV)-mediated transfer of viral invasive factor LMP1. We suggest that soluble inhibitors of UCH-L1 such as LDN-POx offer potential forms of treatment for invasive carcinomas including EBV-positive malignancies.
Insights
Small-molecule inhibitors targeting ubiquitin C-terminal hydrolase L1 (UCH-L1) de-ubiquitinating (DUB) activity, including nanoparticle formulations, reduce cancer cell metastasis. These inhibitors decrease pro-metastatic markers and viral factor transfer in squamous cell carcinoma and nasopharyngeal cell lines.
Area of Science:
- Oncology
- Molecular Biology
- Nanotechnology
Background:
- Ubiquitin C-terminal hydrolase L1 (UCH-L1) is typically found in adult nervous and reproductive systems but is aberrantly expressed in various human cancers.
- UCH-L1's de-ubiquitinating (DUB) activity is increasingly recognized for its pro-metastatic role in carcinomas.
- Epstein-Barr virus (EBV)-associated nasopharyngeal carcinoma (NPC) involves the pro-metastatic protein Latent membrane protein 1 (LMP1).
Purpose of the Study:
- To investigate the anti-metastatic effects of the UCH-L1 DUB inhibitor LDN-57444 in oral squamous cell carcinoma (OSCC) and EBV-positive nasopharyngeal (NP) cell lines.
- To develop and evaluate a nanoparticle formulation (LDN-POx) of LDN-57444 to improve its solubility and efficacy.
- To assess the impact of UCH-L1 inhibition on exosome secretion, pro-metastatic factors, cell motility, and viral factor transfer.
Main Methods:
- Utilized cell lines from advanced OSCC and invasive NP expressing EBV's LMP1.
- Developed polyoxazoline micellar nanoparticles (LDN-POx) to formulate LDN-57444.
- Assessed anti-metastatic effects using in vitro assays measuring cell motility, adhesion, exosome secretion, and pro-metastatic marker levels.
Main Results:
- LDN-57444 and its nanoparticle formulation LDN-POx demonstrated comparable in vitro anti-metastatic effects.
- Inhibition of UCH-L1 DUB activity reduced exosome secretion and lowered pro-metastatic factors within exosomal fractions.
- Treatment suppressed the motility of metastatic squamous carcinoma and EBV-positive NP cells, decreased pro-metastatic markers, reduced cell adhesion, and inhibited LMP1 transfer via extracellular vesicles.
Conclusions:
- Small-molecule inhibitors of UCH-L1 DUB activity, including soluble nanoparticle formulations like LDN-POx, show significant anti-metastatic potential.
- Targeting UCH-L1 offers a promising therapeutic strategy for invasive carcinomas, particularly EBV-positive malignancies.
- LDN-POx represents a viable approach to overcome solubility limitations and deliver UCH-L1 inhibitors for cancer treatment.
More Related Videos
10:16Chick Heart Invasion Assay for Testing the Invasiveness of Cancer Cells and the Activity of Potentially Anti-invasive Compounds
Published on: June 6, 2015
08:32Analysis of Cancer Cell Invasion and Anti-metastatic Drug Screening Using Hydrogel Micro-chamber Array HMCA-based Plates
Published on: October 25, 2018
Related Concept Videos
Inhibition of Cdk Activity
Feedback Inhibition
Buffer Effectiveness
The buffer capacity is the amount of acid or base that can be added to a given volume...
Enzyme Inhibition
Co-activators and Co-repressors
Biological Effects of Radiation